SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22 | -71.8% | 17,264 | -30.6% | 0.00% | -80.0% |
| Q4 2022 | $78 | -99.9% | 24,880 | +63.9% | 0.01% | -16.7% |
| Q4 2021 | $114,000 | -46.0% | 15,176 | +12.1% | 0.01% | -47.8% |
| Q4 2020 | $211,000 | +5.0% | 13,543 | -36.2% | 0.02% | -32.4% |
| Q3 2020 | $201,000 | -54.6% | 21,232 | -57.0% | 0.03% | -33.3% |
| Q2 2020 | $443,000 | +321.9% | 49,426 | +293.9% | 0.05% | +410.0% |
| Q4 2019 | $105,000 | -79.6% | 12,548 | -77.9% | 0.01% | -75.0% |
| Q3 2019 | $514,000 | +111.5% | 56,760 | +123.2% | 0.04% | +185.7% |
| Q1 2019 | $243,000 | +88.4% | 25,430 | +126.7% | 0.01% | +100.0% |
| Q4 2018 | $129,000 | -45.6% | 11,215 | -32.7% | 0.01% | -30.0% |
| Q2 2018 | $237,000 | -67.4% | 16,662 | -56.5% | 0.01% | -74.4% |
| Q1 2018 | $727,000 | – | 38,284 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |